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ABSTRACT Galactoseisacommonmonosaccharidethatcanbeutilizedbyalllivingorganismsviatheactivitiesofthreemainen-
zymes that make up the Leloir pathway: GalK, GalT, and GalE. In Bacillus subtilis, the absence of GalE causes sensitivity to exog-
enousgalactose,leadingtorapidcelllysis.Thiseffectcanbeattributedtotheaccumulationoftoxicgalactosemetabolites,since
thegalEmutantisblockedintheﬁnalstepofgalactosecatabolism.Inascreenforsuppressormutantsrestoringviabilitytoa
galEnullmutantinthepresenceofgalactose,weidentiﬁedmutationsin sinR,whichisthemajorbioﬁlmrepressorgene.These
mutationscausedanincreaseintheproductionoftheexopolysaccharide(EPS)componentofthebioﬁlmmatrix.Wepropose
thatUDP-galactoseisthetoxicgalactosemetaboliteandthatitisusedinthesynthesisofEPS.Thus,EPSproductioncanfunc-
tionasashuntmechanismforthistoxicmolecule.Additionally,wedemonstratedthatgalactosemetabolismgenesplayanes-
sential role in B. subtilis bioﬁlm formation and that the expressions of both the gal and eps genes are interrelated. Finally, we
propose that B. subtilis and other members of the Bacillus genus may have evolved to utilize naturally occurring polymers of
galactose,suchasgalactan,ascarbonsources.
IMPORTANCE Bacteriaswitchfromunicellulartomulticellularstatesbyproducingextracellularmatricesthatcontainexopoly-
saccharides.Insuchaggregates,knownasbioﬁlms,bacteriaaremoreresistanttoantibiotics.Thismakesbioﬁlmsaserious
probleminclinicalsettings.Theresilienceofbioﬁlmsmakesthemveryusefulinindustrialsettings.Thus,understandingthe
productionofbioﬁlmmatricesisanimportantprobleminmicrobiology.Instudyingthesynthesisofthebioﬁlmmatrixof Ba-
cillus subtilis, we provide further understanding of a long-standing microbiological observation that certain mutants defective
intheutilizationofgalactosebecamesensitivetoit.Inthiswork,weshowthatthetoxicityobservedbeforewasbecausecells
weregrownunderconditionsthatwerenotpropitioustoproducetheexopolysaccharidecomponentofthematrix.Whencells
aregrownunderconditionsthatfavormatrixproduction,thetoxicityofgalactoseisrelieved.Thisallowedustodemonstrate
thatgalactosemetabolismisessentialforthesynthesisoftheextracellularmatrix.
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T
he Gram-positive bacterium Bacillus subtilis forms surface-
attached matrix-enclosed multicellular communities known
as bioﬁlms (1). The matrix, which provides structure to the bio-
ﬁlm, is composed of two very different components: an amyloid-
like protein, TasA, and an exopolysaccharide (EPS) (2, 3). The
presence of EPS is a nearly universal feature of bioﬁlms and in
some cases accounts for 90% of the colony mass (4). In B. subtilis,
a 15-gene operon, epsA to epsO (epsA-O), encodes the proteins
responsible for the synthesis of this polysaccharide (3, 5). While
the structural role of the EPS in the bioﬁlm has been well estab-
lished, the precursor metabolites used in its synthesis and its ﬁnal
composition are not known (2).
In many bacterial species, sugar nucleotides, such as UDP-
glucose and UDP-galactose, are essential for exopolysaccharide
biosynthesis.Thus,deletionofthegenesinvolvedinthemetabolic
pathwaysforthesenucleotidesugarsoftenleadstotheinabilityto
produce exopolysaccharides (6). One of the major sugar metabo-
lism pathways is the Leloir pathway, which allows the catabolism
of galactose via conversion to UDP-galactose (Fig. 1A) (7). In the
ﬁrststepofthepathway,galactoseisphosphorylatedbythegalac-
tokinase GalK. The resulting product, galactose-1-phosphate
(Gal-P), is then converted to UDP-galactose by the galactose-1-
phosphate uridyltransferase GalT, which exchanges the glucose-
1-phosphate (Glu-P) moiety of UDP-glucose with Gal-P, thereby
producing UDP-galactose (UDP-Gal) and releasing glucose-1-
phosphate. Glucose-1-phosphate (via conversion to glucose-6-
phosphate) can then be catabolized by entering glycolysis. The
ﬁnal step is performed by GalE, a UDP-galactose-4-epimerase,
which catalyzes the reversible conversion between UDP-Gal and
UDP-glucose (UDP-Glc) (Fig. 1A), thereby regenerating UDP-
glucose. In addition, B. subtilis GalE is capable of interconverting
UDP-N-acetylglucosamine (GlcNAc) and UDP-N-
acetylgalactosamine (GalNAc) (8).
The Leloir pathway is highly conserved in all organisms (9). In
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pathway leads to a disorder called galactosemia, which results in
general organ damage if galactose is ingested. This effect results
from the accumulation of a toxic galactose intermediate. In bac-
teria, galE mutants of Escherichia coli and Salmonella enterica se-
rovarTyphimuriumareunabletogrowinmediumsupplemented
with galactose (10–12). As with the human disease, this growth
inhibitionisattributedtoaccumulationoftoxicintermediateme-
tabolites from galactose (12). Similarly, deletion of galE in the
B. subtilis domesticated strain 168 causes sensitivity to exogenous
addition of galactose (13).
Here we show that deletion of the galE gene in the less domes-
ticated B. subtilis strain NCIB3610 also induces sensitivity to ex-
ogenous galactose due to accumulation of UDP-galactose, which
is toxic under planktonic growth conditions. During bioﬁlm for-
mation,weobservedthatproductionofEPScouldserveasashunt
pathwayforUDP-galactose,thusrelievingthegalactosetoxicityin
the galE mutant. Additionally, we report that synthesis of UDP-
galactose is required for exopolysaccharide biosynthesis and that
thetranscriptionsofthegalandepsgenesareinterrelated.Finally,
we show that B. subtilis is able to acquire galactose through the
catabolism of galactan, a polymer of galactose often found in nat-
ural settings.
RESULTS
GalactoseinducesrapidcelllysisinthegalEmutantofB.subtilis
by accumulation of toxic metabolites. A galE deletion mutant of
B. subtilis strain NCIB3610 displayed a growth curve similar to
that of the wild type when grown in LB (Luria-Bertani) medium.
Galactose requires the presence of arabinose to be taken up by
B. subtilis; therefore, the medium was simultaneously supple-
mented with 0.01% arabinose in this work to facilitate the uptake
of galactose (14). When cultivated in LB medium supplemented
with 0.5% (wt/vol) galactose and 0.01% arabinose, the galE mu-
tantdisplayedaseveregrowthdefect(Fig.1B).Infact,concentra-
tionsofgalactoseaslowas0.005%impairedthegrowthofthegalE
mutant (see Fig. S1 in the supplemental material). The galE mu-
tant was able to grow for a few hours in the presence of galactose,
buttheopticaldensityat600nm(OD600)decreasedafterreaching
about 0.8, suggesting that cell lysis had occurred (open squares in
Fig. 1B). To test whether lysis was occurring, samples of galE
mutantculturesweretakenafter3hofgrowthinLBmediumorin
LB medium that had been supplemented with galactose. The cells
were then treated with live/dead stain (Invitrogen). Fluorescence
microscopy imaging showed that in the absence of galactose, the
majority of galE mutant cells were alive (Fig. 1C, falsely colored
green) and that there was high abundance of dead cells in the
presence of galactose (Fig. 1C, falsely colored red). Additionally,
these dying cells displayed abnormal bulges at one end or in the
middle of the cell, suggesting that they were undergoing lysis (ar-
rows in Fig. 1C). These results conﬁrmed that galactose causes
toxicity,whichleadstocelldeathinthegalEmutantofB.subtilis.
Thisobservationisalsoinagreementwithapreviousreportdem-
FIG 1 Galactose toxicity-induced cell lysis in the galE mutant by galactose metabolites. (A) Leloir pathway for galactose metabolism in bacteria. galK encodes
agalactosekinase,galTencodesagalactose-1-phosphateuridyltransferase,andgalEencodesaUDP-galactoseepimerase.Glc,glucose;Gal,galactose.(B)Growth
ofthewildtype(3610)(WT)andthegalEmutant(FC300)inLB(Luria-Bertani)mediuminthepresenceorabsenceof0.5%galactose.Arrowsindicatethetime
pointatwhichcellsampleswerecollectedformicroscopyanalyses(resultsshowninpanelC).(C)Live/deadcellstainingoftheB.subtilisgalEmutant(FC300).
CellsweregrowninLBmediumwithorwithoutsupplementationof0.5%galactoseandcollected3hafterinoculation(indicatedbyarrowsinpanelB).Cellswere
treated with dyes for live/dead cell staining and examined under ﬂuorescence microscopy. Arrows points to cells showing distinct bulge-like structures. (D)
Growth of the wild type (3610) and galE mutant (FC300) of B. subtilis in LB medium supplemented or not supplemented with 0.5% galactose (Gal) or 0.5%
D-oxy-galactose (D-oxy-Gal). (E) Growth of the galETK (YC563), galETK amyE::galK (YC810), and galETK amyE::galTK (YC811) mutants in LB medium
supplemented or not supplemented with 0.5% galactose (Gal).
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mutant derived from the domesticated B. subtilis strain 168 (13).
It was further reported that the toxic effect of galactose on the
B. subtilis galE mutant was due to accumulation of toxic interme-
diate metabolites, such as phosphorylated galactose (Gal-P) and
UDP-galactose (UDP-Gal) (Fig. 1A) (13). To evaluate which one
of these two metabolites caused cell lysis, we tested the effect of
D-oxy-galactose on the wild type and the galE mutant. GalK can
phosphorylate this compound, but the product cannot be further
convertedbyGalT,leadingtoanartiﬁcialincreaseof D-oxy-Gal-P
inthecells.-D-oxy-Gal-PhasbeenshowntobetoxictoE.coliand
other bacteria (15). Since the addition of 0.5% of D-oxy-galactose
in LB medium did not cause a signiﬁcant growth defect in a galE
mutant or in wild-type cells, it is unlikely that Gal-P is toxic for
B. subtilis (Fig. 1D, circles).
In a different approach, we deleted the galKT genes in a galE
background. If the toxic metabolite is produced by the GalK
and/or GalT enzymes, deleting both genes should block galactose
utilization and should restore viability to galE cells in the pres-
ence of galactose. Indeed, the galE galKT triple mutant with-
stoodthepresenceofexogenousgalactoseinthemedium(Fig.1E,
diamonds). We investigated whether the toxic metabolite was
Gal-P(theproductofGalK)orUDP-Gal(theproductofGalT)by
restoring to the galE galKT triple mutant strain either galK
alone or both galT and galK at the chromosomal amyE locus. As
shown in Fig. 1E, the strain to which only galK was restored was
still resistant to galactose toxicity, but the presence of both galK
and galT at the amyE locus restored sensitivity to galactose (Fig.
1E). This result again supported the idea that UDP-Gal, but not
Gal-P, is the toxic metabolite in B. subtilis.
Characterizationofthegalactose-resistantsuppressorofthe
galEmutant.Asexpected,thegalEmutantwasunabletoform
coloniesonLBagarplatessupplementedwith0.5%galactose(Fig.
2A). This allowed us to isolate colonies containing suppressor
mutations that allowed the galE mutant to grow in the presence
of galactose. Using the genetic approaches described in Materials
and Methods, we mapped the mutations in order to understand
how they help cells cope with galactose toxicity. As might be ex-
pected, strains with mutations in two of these suppressors, supA1
and supA2 (Fig. 2A), were found to bear mutations in galK. The
supA1 mutant contained a frameshift mutation at nucleotide po-
sition 70 of the galK open reading frame, resulting in a truncated
GalK protein, and the supA2 strain had a point mutation in the
codon for a highly conserved alanine at residue 24 (A24P) (Fig.
S2). Both mutations likely caused loss of GalK enzymatic activity,
thus impairing the accumulation of the toxic UDP-Gal metabo-
lites by blocking the utilization of galactose (see Table S1 in the
supplemental material). Accordingly, reintroduction of func-
tional galKT genes at the amyE locus of the supA1 and supA2
suppressor mutants restored sensitivity to galactose toxicity (Fig.
2A).
Toreducetheprobabilityofobtainingsuppressormutationsin
galKT,asecondcopyofthesegeneswasintroducedintothegalE
strain at the amyE locus. The resulting strain was similarly sensi-
tivetoexogenousgalactose(datanotshown)butstilloccasionally
gave rise to resistant colonies on LB medium-0.5% galactose
plates,suggestingthatanotherunknownmechanism(s)maycon-
fer resistance to galactose toxicity in galE mutant cells. The sup-
pressor phenotype of these resistant colonies was veriﬁed, and
suppressor mutations in two such suppressor strains (supB1 and
supB2mutants)weremapped.BoththesupB1andsupB2suppres-
sorstrainswerefoundtoharbormutationsinthesinRgene,which
encodes a master transcriptional regulator that represses genes
involved in bioﬁlm formation (Fig. 2B; see also Table S1 in the
supplementalmaterial).ThesupB1mutanthadanonsensemuta-
tionatcodon78ofthegene,whereasthesupB2mutantadapoint
FIG 2 Producing EPS (exopolysaccharide) as a shunt pathway for toxic metabolites from galactose. (A to C) Characterization of galE suppressor mutants
resistant to galactose toxicity. Cells were inoculated on LB agar plates supplemented with 0.5% galactose. (D) Overexpression of the epsA-O operon suppressed
galactosetoxicityinthegalEmutant.galE::tetPhyspank-epsA-Ocells(YC776)weregrowninMSggmediaintheabsence(left)orpresence(right)of0.1%galactose
and with various amounts of IPTG (see the key). The galE epsA-O double mutant is also included as a control. (E) Sugar composition analysis of EPS from
wild-type (3610) or epsA-O mutant (YC771) pellicles. Glc, glucose; GalNAc, N-acetyl-galactose; Gal, galactose.
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(L74S).AsSinRisknowntorepressmanybioﬁlmgenes,including
the 15-gene epsA-O operon, which produces the matrix exopoly-
saccharide, we decided to analyze the effect of these point muta-
tions on the expression of the eps genes (3). Using the strains
harboring a PepsA-lacZ reporter construct, we showed that both
sinR suppressor mutations greatly impaired the repressing capac-
ity of SinR, as the expression of the reporter was drastically ele-
vated in both mutants compared to expression in the wild type
(Fig.S3).Second,adoublemutantwithbothgalEandsinRdeleted
was constructed and displayed a much higher resistance to galac-
tose toxicity than the galE single mutant (Fig. 2C), further sup-
porting the hypothesis that sinR inactivation was the explanation
for the suppressor phenotypes of the mutants obtained.
Resistance of the galE sinR double mutant to galactose tox-
icity depends on the production of exopolysaccharide. SinR
doesnotinﬂuencegalTorgalKexpression(datanotshown),thus
pointing to a unique mechanism for the loss of galactose toxicity
in galE sinR cells. As the eps genes were highly induced in the
suppressor mutants, we assayed whether a deletion of the epsA-O
operon could reverse the resistance phenotype of the galE sinR
double mutant. Indeed, the galE sinR epsA-O triple mutant was
unabletogrowinthepresenceofgalactose(Fig.2C).Importantly,
the epsA-O mutation itself in an otherwise wild-type back-
ground did not affect galactose toxicity (Fig. 2C) likely because
GalE converts UDP-galactose to UDP-glucose, thus avoiding ac-
cumulation of the toxic UDP-galactose. Furthermore, deleting
otherSinR-regulatedgenes,suchasthetapA-sipW-tasAoperonor
thelutABCoperon,didnotshowthesameeffect(datanotshown)
(16, 17). These results suggest that suppression of galactose toxic-
ity by SinR inactivation requires an increased expression of the
epsA-O operon. If this is the case, then overexpression of epsA-O
shouldhavethesameeffectasasinRmutationandthusrestorethe
viability of galE mutant cells in the presence of galactose. We
tested this hypothesis by replacing the native epsA-O promoter
with an IPTG (isopropyl--D-thiogalactopyranoside)-inducible
hyspank promoter (epsA-OPhyspank-epsA-O)i nt h egalE mutant.
The resulting cells were grown in MSgg medium (18) supple-
mented with various amounts of IPTG. In the presence of 0.1%
galactose, cells with maximal epsA-O gene induction grew much
better than those with little or low levels of epsA-O induction,
althoughintheend,signiﬁcantcelllysisstilloccurred(Fig.2D).As
acontrol,intheabsenceofgalactose,IPTGadditiondidnotaffect
cell growth (Fig. 2D). A galE epsA-O mutant was also used as a
controlinthisexperiment.Thus,theproductionofEPSbyexpres-
sion of the epsA-O operon is able to restore growth to a galE mu-
tant in the preshyspankence of galactose.
Producingexopolysaccharidesasashuntpathwayforgalac-
tose toxicity. The above observations led us to hypothesize that a
null mutation of sinR or overexpression of epsA-O can relieve the
toxic effect of galactose by shunting its toxic metabolite (UDP-
Gal)towardincorporationintheEPS.Sincesugarcompositionof
the B. subtilis EPS is not known, we decided to characterize it to
determine if galactose or its derivatives were indeed present in
EPS. To this end, we puriﬁed EPS from wild-type and epsA-O
mutant bioﬁlms and analyzed their sugar compositions as de-
scribed in Materials and Methods. As shown in Fig. 2E, EPS pre-
pared from the wild-type bioﬁlms was rich in glucose (Glc),
N-acetyl-galactose (GalNAc), and galactose (Gal), whereas the
material extracted from the epsA-O mutant completely lacked
N-acetyl-galactose and galactose (Fig. 2E). These results con-
ﬁrmed that galactose and/or its derivatives are constituents of the
bioﬁlm EPS in B. subtilis. We conclude that in B. subtilis, produc-
ing EPS can function as a shunt mechanism for a toxic metabo-
lite(s) from galactose.
ThegalgenesareimportantforbioﬁlmformationinB.sub-
tilis. Exopolysaccharide is a key component of the bioﬁlm matrix
inB.subtilissincemutantsdeﬁcientinEPSproductionareunable
to form bioﬁlms (2, 3). As galactose is present in puriﬁed EPS, we
examined the importance of this sugar for bioﬁlm formation. We
took advantage of the fact that the galE mutant cannot convert
UDP-glucosetoUDP-galactose,andtherefore,itreliesentirelyon
exogenous galactose to synthesize UDP-Gal (Fig. 1A). If this nu-
cleotidesugarisrequiredforEPSbiosynthesis,thenintheabsence
of an exogenous source of galactose, a galE mutant should be
defectiveinEPSbiosynthesisandthusimpairedinbioﬁlmforma-
tion. As observed in Fig. 3, wild-type cells form ﬂoating bioﬁlms
(pellicles) that appear white in a top-down view when inoculated
intoabioﬁlm-inducing,liquidmediumlackinggalactose(MSgg).
In contrast, the galE mutants form only a broken pellicle that
strikingly resembles that of the epsA-O mutant (see Fig. S4 in the
supplemental material). As predicted, addition of exogenous ga-
FIG3 Thegalgenesareimportantforbioﬁlmformation.Top-downviewofpellicleformationofthewildtype(3610)andthegalE(FC300),galTK(YC532),
and galE galTK (YC563) mutants in MSgg medium with or without 0.5% galactose.
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quired UDP-Gal could then be synthesized via GalK and GalT
(Fig.3).DeletionofgalKThadnoinﬂuenceonbioﬁlmformation
due to the presence of galE, but the galE galKT triple mutant was
unable to form a pellicle even in the presence of galactose, since
these cells could no longer synthesize UDP-Gal (Fig. 3). It is also
important to note that under bioﬁlm-inducing conditions, when
eps gene expression is normally high, adding galactose to the galE
mutantdidnotinhibitgrowth,whichwasreadilyobservedforthe
same cells under planktonic growth conditions that do not favor
matrixproduction(Fig.3).ThisreinforcedtheideathatB.subtilis
shunts UDP-Gal into exopolysaccharide synthesis during bioﬁlm
formation.
Regulation of the gal genes is interrelated with that of the
epsA-O operon in B. subtilis. Our ﬁndings that the galEKT genes
arerequiredforbioﬁlmformation(Fig.3)provedthatnucleotide
sugar precursors, such as UDP-Gal, are crucial for EPS synthesis.
Hence,wewonderedwhetherthegalgeneswereregulatedincon-
cert with the epsA-O operon during bioﬁlm formation in B. sub-
tilis.ToinvestigatetheregulationofthegalEgene,weconstructed
a reporter fusion in which the promoter region of the galE gene
was fused to a lacZ reporter (PgalE-lacZ). This construct was then
integratedintotheamyElocusofthewildtypeandvariousmutant
strains.WeﬁrstmeasuredlacZexpressioninwild-typecellsgrown
in MSgg and observed that PgalE-lacZ activity was signiﬁcantly
induced at late times (Fig. 4A), similar to what was shown for
expression of the epsA-O operon (19). We previously demon-
stratedthatEPSbiosynthesisisindirectlycontrolledbythemaster
regulator Spo0A via the expression of the antirepressor SinI (3).
Thus,deletionofeitherofthesegenesblockstheexpressionofthe
epsA-O operon (Fig. 4E). While a spo0A deletion impaired galE
gene induction, a sinI mutant had no effect (Fig. 4A). This result
suggestsacoordinatedregulationofthegalEgeneandtheepsA-O
operon mediated by Spo0A, but independent of sinI activation,
during bioﬁlm formation. It is notable that the basal level of galE
gene expression was quite signiﬁcant (Fig. 4A). This is consistent
with the idea that GalE is also important in making UDP-Gal for
othercellularprocessesduringnormalcellgrowthwhentheEPSis
not being synthesized (20).
WhilegalEislocatedelsewhereonthechromosomeasamono-
FIG4 RegulationofthegalgenesinB.subtilis.(A)-Galactosidaseactivitiesofthewildtype(YC777),thesinImutant(YC778),andthespo0Amutant(YC779),
which harbor the PgalE-lacZ reporter at the amyE locus on the chromosome. Cells were grown in MSgg shaking culture, and hour 5 postinoculation was
approximately the start of the stationary phase. (B) Genetic organization of the ywcC-gtcA-galK-galT gene cluster in B. subtilis. (C) Results of the reverse
transcription-PCR(RT-PCR)usingprimersthatamplifypartofthemRNAtranscriptoftheywcC-gtcA-galK-galTgenecluster.Theampliﬁedregion(about3kb)
is indicated by the horizontal double-headed arrow in panel B. PCR ampliﬁcation without reverse transcription (RT) was used as a negative control. (D)
-Galactosidase activities of the wild type (YC783) and the ywcC mutant (YC784), which contain the PywcC-lacZ reporter at the chromosomal amyE locus. (E)
Proposed model for the concerted regulation of the epsA-O operon and the gal genes in B. subtilis. Under normal bioﬁlm-inducing conditions, the master
regulatorSpo0AactivatesbothsinI,whichleadstoderepressionoftheepsA-Ooperon,andgalE,whoseproteinproductgeneratesUDP-Galasakeynucleotide-
sugar substrate for EPS biosynthesis. Under alternative conditions, a TetR-like regulator, YwcC, derepresses both slrA, which also leads to derepression of the
epsA-O operon and galK and galT in the same operon, whose protein products convert exogenous galactose to UDP-Gal.
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genes (Fig. 4B). The gtcA gene encodes a putative glycosyltrans-
ferase possibly involved in teichoic acid biosynthesis, whereas
ywcC encodes a TetR-type repressor. In previous studies, we and
others have shown that YwcC represses the divergently tran-
scribed gene slrA, a SinR antirepressor (Fig. 4B) (21, 22). There-
fore,YwcCisanegativeregulatorforbioﬁlmformation.Although
itwaspreviouslypostulatedthatywcC,gtcA,galK,andgalTmight
constitute an operon, there was no experimental evidence for this
(22).Weusedreversetranscription-PCR(RT-PCR)withapairof
primers extending across all four genes to investigate if they were
cotranscribed. As shown in Fig. 4C, a fragment of about 3 kb was
ampliﬁed in the RT-PCR (with reverse transcriptase), conﬁrming
that ywcC, gtcA, galK, and galT are cotranscribed as a single unit.
WhetherornotgalKandgalTareexclusivelytranscribedfromthe
promoter upstream of ywcC will need further investigation. The
negative control, without reverse transcriptase, did not produce a
detectablefragment.Wethentestedwhetherthisoperonwasauto-
regulated by the YwcC repressor using a transcriptional fusion of
theregulatoryregionupstreamofywcCandlacZ(PywcC-lacZ).The
activity of the PywcC-lacZ reporter was found to be about 2-fold
higher in the ywcC mutant than in the wild type (Fig. 4D), indi-
catingthatthewholeoperonisnegativelyautoregulatedbyYwcC.
Basedonourﬁndings,weproposeamodelinwhichregulation
of the epsA-O operon (genes for EPS biosynthesis) and that of the
gal genes (genes in the UDP-Gal metabolism pathway) are coor-
dinated (Fig. 4E). This model proposes two different pathways
leading to bioﬁlm formation (Fig. 4E). Under bioﬁlm-inducing
conditions,suchasgrowthinMSggmedium,themasterregulator
Spo0A induces eps gene transcription via production of the SinI
antirepressor. At the same time, Spo0A stimulates galE transcrip-
tion, leading to an increased production of UDP-Gal and thus
providingsufﬁcientamountsofthiskeynucleotidesugarasasub-
strate for EPS biosynthesis. A second pathway for bioﬁlm forma-
tion involves YwcC, which upon receiving an as-yet-unknown
signal, derepresses both the galKT genes and the paralogous anti-
repressor gene slrA, leading to UDP-Gal biosynthesis and dere-
pression of the epsA-O operon. Since galactose is required for
UDP-Gal synthesis by GalK and GalT, one might predict that
YwcC directly or indirectly senses galactose as a signal. Efforts to
detectsucharesponsehave,however,beenunsuccessful.Alterna-
tively, perhaps YwcC recognizes and responds to a galactose-con-
taining oligosaccharide or other breakdown product of a
galactose-rich polysaccharide.
Aconservedmetabolicpathwayforutilizationofgalactanin
B. subtilis. In the soil and the rhizosphere, the natural habitat of
B. subtilis, galactose is often found as part of polymers such as
galactan, an abundant molecule in the cell wall of plants and of
certainbacteria(23,24).Thus,galactanmayconstituteanimpor-
tant source of galactose for B. subtilis in settings where it interacts
withplantrootsandothersoilmicroorganisms.Apreviousreport
foundthatthecycB-ganBoperoninB.subtilismightbeinvolvedin
galactan degradation (25). Within that gene cluster, cycB, ganP,
and ganQ encode a putative ABC transporter system, while ganA
encodesa-galactosidase-hydrolyzinggalactanandganBencodes
an endo--1 to -4-galactosidase (25). Next to this gene cluster is
lacR, which encodes a LacI family transcriptional repressor and
might regulate the nearby gene cluster (Fig. 5A) (26).
To conﬁrm the involvement of these genes in galactan utiliza-
tion, we constructed a strain lacking the entire gene cluster (cycB-
ganPQAB). This mutant, together with the wild type, the galE
mutant, and the galKT mutant, was grown in a modiﬁed M9
minimalmediumwitheither0.5%galactanor0.5%glucoseasthe
solecarbonsource.Thegrowthofallofthemutantswassimilarto
thatofthewildtypewhencellsweregrowninthepresenceof0.5%
glucoseasthesolecarbonsource(Fig.5B).However,comparedto
thewildtype,thecycB-ganPQABmutantshowedslightlyimpaired
growthinminimalmediumcontaininggalactanasthesolecarbon
source (Fig. 5B). This limited growth impairment indicates that
while the cycB-ganPQAB operon appears to be involved in galac-
tan utilization, additional enzymes might contribute to galactan
utilizationinB.subtilis.Thisissupportedbyabioinformaticanal-
ysis of the B. subtilis genome indicating that other homologs of
genesinthecycB-ganPQABoperonarealsopresentinthegenome
ofB.subtilis(datanotshown).Incontrast,boththegalKTandthe
galE mutants were unable to grow in the presence of galactan as
thesolecarbonsource(Fig.5B).Thisarguesthatgalactanmustbe
ﬁrst broken down to galactose and then converted to glucose via
the Leloir pathway. This idea was further supported by growing
the galE cells in LB medium supplemented with 0.5% galactan.
We found that the galE mutant could not grow to a high cell
density and displayed a cell lysis phenotype similar to that de-
scribed above when cells were cultivated with 0.5% galactan (Fig.
5C).DeletionofthecycB-ganPQABoperon,encodingthegalactan
utilization pathway, only partially suppressed the toxicity in the
galE mutant, once again suggesting a redundant pathway for ga-
lactan utilization in this strain (Fig. 5C).
DISCUSSION
We have shown that galactose metabolism plays a central role in
bioﬁlm formation by B. subtilis. Whereas accumulation of UDP-
galactose can be toxic to B. subtilis during planktonic growth, it is
requiredforthebiosynthesisofEPSasanucleotidesugarsubstrate
and thus for matrix production. Consistently with the above, the
genes encoding the Leloir pathway for galactose catabolism and
the operon responsible for EPS biosynthesis show coordinated
transcriptionalregulation.Finally,weobservedthatB.subtilisalso
has the capacity to degrade galactan and thus acquire galactose
from this naturally occurring polymer.
Galactose has been shown to be essential for the synthesis of
various exopolysaccharides, such as colanic acid in E. coli (27).
Similarly, enzymes in the Leloir pathway, and in particular the
GalE epimerase, have been correlated with production of exopo-
lysaccharide in Streptococcus thermophilus, Porphyromonas gingi-
valis, and Neisseria strains (6, 28–31). Thus, our observation that
UDP-galactose synthesis is necessary for exopolysaccharide bio-
genesis in B. subtilis is consistent with what has been observed for
other bacteria.
Prior to this study, little was known about the requirement for
nucleotide sugars in the production of B. subtilis exopolysaccha-
ride. It had been demonstrated that GtaB, which catalyzes the
formation of UDP-glucose from glucose-1-P and UTP, is neces-
saryforbioﬁlmformationinLBmediumbytheB.subtilisdomes-
ticatedstrain168(32).Theauthorsofthatworksuggestedthatthe
requirement for this molecule meant that UDP-glucose is either
involved as a signaling molecule or as a precursor for synthesis of
EPS. Since our analysis of B. subtilis exopolysaccharide showed a
large amount of glucose and galactose residues, it is reasonable to
conclude that UDP-glucose, like UDP-galactose, is required as a
precursor for EPS synthesis during bioﬁlm formation.
Chai et al.
6
® mbio.asm.org July/August 2012 Volume 3 Issue 4 e00184-12We propose a working model (Fig. 6A) for the catabolism of
galactanbyB.subtilisandfortheutilizationofgalactoseeitherasa
carbon source via the Leloir pathway or as a nucleotide-sugar
substrateforEPSbiosynthesisduringbioﬁlmformation.Interest-
ingly, the cycB-ganPQAB operon is present not only in B. subtilis
but also in several related bacterial species (Fig. 6B). In two plant-
associated Bacillus species, B. licheniformis and B. amyloliquefa-
ciens, these genes are not only conserved and clustered but also
grouped with the gal genes (Fig. 6B). A similar genetic organiza-
tion of these genes was also found in a gut-colonizing bacterium,
Lactobacillus acidophilus. This gene cluster was indeed recently
proposed to be involved in the utilization of host-released poly-
mers of galactose by L. acidophilus (33). Our study thus provides
an interesting example of how bacteria have adapted to utilize
host-derived sugars not only as a carbon source, but also for the
establishment of a close symbiotic relationship between the bac-
terium and the host.
MATERIALS AND METHODS
Bacterial strains, media, and reagents. For general purposes, B. subtilis
strainsPY79,NCIB3610,andtheirderivativesweregrowninLBmedium
(10 g tryptone, 5 g yeast extract, and 5 g NaCl per liter of broth) at 37°C.
For assays of bioﬁlm formation, MSgg medium was used and cells were
incubatedat23°C.TherecipeforMSggmediumwasdescribedpreviously
(18). E. coli strains were grown in LB medium at 37°C, and strain DH5
was used for molecular cloning. A list of strains, plasmids, and oligonu-
cleotides used in this work are summarized in Tables S2 and S3 in the
supplementalmaterial.Antibioticswereaddedtothemediaatthefollow-
ing concentrations for B. subtilis strains: 10 gm l 1 tetracycline,
100gml 1spectinomycin,10gml 1kanamycin,5gml 1chloram-
phenicol, and 1 gm l 1 erythromycin. For E. coli strains, ampicillin was
added at 100 gm l 1. Galactose, deoxygalactose, arabinose, xylose, ga-
lactan, and other chemicals were purchased from Sigma.
Strainconstruction.Generalmethodsformolecularcloningfollowed
publishedprotocols(34).SPP1phage-mediatedtransductionwasusedto
transfer antibiotic-marked DNA fragments among different strains (35).
Long ﬂanking PCR mutagenesis was applied to generate insertional dele-
tion mutations (36).
The insertional mutations in galK-galT, epsA-O, and cycB-ganPQAB
gene clusters were generated by long ﬂanking PCR mutagenesis by using
primers galTK-P1, -P2, -P3, -P4, eps-P1, -P2, -P3, -P4, and gan-P1, -P2,
-P3, -P4 (see Table S3), respectively. To construct the inducible gaK-galT
fusion (Physpank-galTK), the coding region of galK-galT was ampliﬁed by
PCR using 3610 genomic DNA as the template and the primers galTK-F1
andgalTK-R1.ThePCRproductswereclonedintoNheIandHindIIIsites
of the vector pDR111 (gift of D. Rudner). The resulting recombinant
plasmid(pYC245)wasﬁrstintroducedintoPY79bytransformation.The
FIG 5 Utilization of galactan by B. subtilis. (A) Genetic organization of the putative gene cluster for galactan utilization in B. subtilis. ganB encodes a putative
endo-1,4-beta-galactosidase, ganA encodes a putative -galactosidase, cycB-ganP-ganQ encodes a sugar transportation system, and lacR encodes a LacI family
transcription repressor. (B) Growth of the wild type (3610), cycB-ganPQAB mutant (YC1063), galE mutant (FC300), and galKT mutant (YC532) in
modiﬁed M9 minimal medium with 0.5% galactan as the sole carbon source. As a control, these strains were also grown in M9 minimal medium with 0.5%
glucoseasthesolecarbonsource.(C)StrainsweregrowninLBmedium(lowerleft)orLBmediumsupplementedwith0.5%galactan(lowerright)totestgalactan
toxicity. Strains are designated as follows: WT is strain 3610, cycB-ganPQAB is YC1063, galE is FC300, and cycB-ganPQAB galE is YC1095.
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derivatives by SPP1 phage-mediated transduction.
To construct the inducible gaK fusion (Physpank-galK), the plasmid
pYC245 was digested with NheI to remove a large internal fragment of
galT. After digestion, the plasmid was religated and transformed into
DH5. The resulting recombinant plasmid contains functional galK only
under the control of the hyspank promoter. This fusion construct was
introduced into 3610 derivatives by following steps similar to those de-
scribed above.
To construct the reporter fusion PgalE-lacZ, the promoter region of
galE was ampliﬁed by PCR. PCR products were cloned into EcoRI and
BamHI sites of the vector pDG268 (36) to make a promoter-lacZ tran-
scriptional fusion. The inducible fusion epsPhyspank-eps was constructed
in FC598, which was a gift of Frances Chu. The construct was introduced
into 3610 derivatives by SPP1 phage-mediated transduction.
Live/deadcellstaining.Live/deadstainingfollowedtheprotocolpro-
vided by the manufacturer (Invitrogen, CA). In brief, galE (FC300) cells
weregrowninLBmediuminshakingcultureinthepresenceorabsenceof
0.5% galactose. Three hours after inoculation, cell samples were collected
andwashedwithphosphate-bufferedsaline(PBS)buffertwice.Cellswere
resuspended and diluted to about 5  107 cells per ml in PBS buffer. One
microliterofreconstitutedﬂuorescentreactivedyewasaddedtoonemil-
liliter of the cell suspension and mixed well. Cell samples were incubated
on ice for 30 min and were concentrated for examination by ﬂuorescence
microscopy.
Assays for galactose toxicity. For plate assays of galactose toxicity,
cells were picked from a freshly grown plate and streaked out on an LB
medium plate supplemented with 0.5% galactose and 0.01% arabinose.
Arabinose is added to facilitate uptake of galactose by an arabinose-
inducibletransportersysteminB.subtilis.Theplateswerethenincubated
at 37°C overnight. The next day, pictures of the plates were taken with a
NikonCoolpix400camera.Thegalactosetoxicitywasvisualizedbylackof
growthontheplate.Forassaysofgalactosetoxicityinliquidmedium,cells
were ﬁrst grown in LB medium to exponential phase and then inoculated
1:100intofreshLBliquidmediumsupplementedwith0.5%galactoseand
0.01% arabinose. Cell optical density was measured by an Ultraspec 2000
spectrometer (Pharmacia, NJ) or by a Synergy 2 plate reader (Bio-Tek,
Canada).
Characterization of the suppressor mutations. Cells susceptible to
galactose toxicity were streaked out on LB agar plates supplemented with
0.5% galactose and 0.01% arabinose. Plates were incubated at 37°C for
2 days. Resistant colonies were picked and restreaked on fresh LB
medium-galactose plates to conﬁrm the resistance phenotype. A mini-
Tn10 transposon bearing plasmid pIC333 (38) was introduced into the
suppressor mutants by transformation. Cells were selected for Spcr and
resistance to macrolides, lincosamides, and streptogramins (MLSr)o n
solid medium at 30°C to verify the presence of the pIC333 plasmid in the
suppressor mutants. Resistant colonies were inoculated into LB liquid
mediumandgrownat37°Covernighttoallowforcontinuedcelldivision
and to block replication of pIC333. Following the selection, genomic
DNAs were prepared from the above-described cultures and introduced
into the galE mutant by transformation. Transformants were selected on
LB medium-galactose-spectinomycin plates. Resistant colonies were
picked and veriﬁed for galactose and spectinomycin resistance. The ge-
FIG6 Galactan metabolism in B. subtilis and other bacteria. (A) Proposed pathway in B. subtilis for utilization of naturally occurring galactan. Galactan is ﬁrst
brokendowntogalactotriosebyGanBoutsidethecell.GalactotrioseisthentakenupbythepermeasecomposedofCycB-GanP-GanQandfurtherbrokendown
to galactose by GanA. Galactose is eventually converted to glucose by the enzymes in the Leloir pathway encoded by the gal genes or becomes a sugar substrate
of EPS during bioﬁlm formation. (B) Genetic arrangements of the putative gene clusters for utilization of galactan in various bacteria. In two plant-associated
Bacillus species, B. licheniformis and B. amyloliquefaciens, as well as in a gut-associated bacterium, Lactobacillus acidophilus, the homologous (to cycB-ganPQAB
in B. subtilis) genes whose protein products are predicted to function in the breakdown of galactan to galactose are not only clustered but also grouped with the
gal genes whose protein products are involved in further metabolism of galactose. Conservation of this genetic arrangement of the above-described genesi n
various bacteria implies that these bacteria adapted to utilize host-derived sugar polymers. In L. acidophilus, the gene cluster contains three ganA paralogs (light
green)andtwounknownphage-likegenes(gray).InB.amyloliquefaciens,thetwopermease-likegenes(blue)encodeaputativePtIIsugaruptakesystem,whereas
in L. acidophilus, a single lacS gene (blue) encodes a putative sugar permease.
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tationthatconfersgalactoseresistancewascalculated.Theﬂankingregion
ofthemini-Tn10insertionwasthensequencedtoconﬁrmthepresenceof
the suppressor mutations.
-Galactosidase assays. A detailed protocol for assays of
-galactosidase activities was published previously (17).
Assays of bioﬁlm formation. For both colony formation and pellicle
development, we followed a protocol that was described previously (17).
Analysis of the sugar compositions of B. subtilis EPS. Cells of either
the wild type or the epsA-O mutant were inoculated into 1 liter of MSgg
liquid medium in standing culture and left at 30°C for 5 days. Pellicles
were harvested, washed with distilled water, and centrifuged. Cell pellets
were resuspended in PBS buffer and were mildly sonicated to separate
exopolysaccharides from cells. Cells were pelleted, and the soluble frac-
tions with released exopolysaccharides were then precipitated with 5 vol-
umes of isopropanol overnight at 4°C. The pellets were centrifuged, ly-
ophilized, and resuspended in distilled water. The lyophilized
resuspension was dialyzed (molecular weight cutoff [MWCO]  3,500)
against distilled water overnight. Glycosyl composition analysis was per-
formed by combined gas chromatography-mass spectrometry (GC/MS)
of the per-O-trimethylsilyl (TMS) derivatives of the monosaccharide
methyl glycosides produced from the samples by acidic methanolysis.
Methyl glycosides were ﬁrst prepared from 500 g of the dry sample by
methanolysis in 1 M HCl in methanol at 80°C for 18 to 22 h, followed by
re-N-acetylation with pyridine and acetic anhydride in methanol (for de-
tectionofaminosugars).Thesampleswerethenper-O-trimethylsilylated
by treatment with Tri-Sil at 80°C for 30 min. GC/MS analysis of the TMS
methyl glycosides was performed on an HP 5890 gas chromatograph in-
terfacedwithamodel5970massselectivedetector(MSD),usingaSupelco
DB-1 fused-silica capillary column (inside diameter, 30 m by 0.25 mm).
Reverse transcription-PCR. 3610 cells were grown in LB medium to
exponential phase. Cells were harvested, and total RNA was harvested
using the RNeasy minikit (Qiagen). Total RNA was used as a template in
reverse transcription reactions carried out using SuperScript II reverse
transcriptase (Invitrogen). Subsequently, in the regular PCRs, puriﬁed
cDNA from the above-described experiments was used as the template,
and primers gal-RT-F1 and gal-RT-R1 were also included. PCR products
were size fractionated on an agarose gel.
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